DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Alemtuzumab, Rituximab ( DrugBank:
Rituximab
,
Alemtuzumab
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
63
特発性血小板減少性紫斑病
1
63. 特発性血小板減少性紫斑病
臨床試験数
:
391
/
薬物数
:
235
- (
DrugBank
:
50
) /
標的遺伝子数
:
49
-
標的パスウェイ数
:
139
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00749112
(
ClinicalTrials.gov
)
August 2008
8/9/2008
Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
Low Doses of Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune Cytopenias
Idiopathic Thrombocytopenic Purpura;Anemia, Hemolytic, Autoimmune
Drug:
Alemtuzumab, Rituximab
Hospital Universitario Dr. Jose E. Gonzalez
NULL
Completed
16 Years
N/A
Both
19
Phase 2/Phase 3
Mexico